Article Versions Notes

Thebault E, Piperno-Neumann S, Tran D, Pacquement H, Marec-Berard P, Lervat C, Castex M-P, Cleirec M, Bompas E, Vannier J-P, et al. Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials? Cancers. 2021; 13(7):1683. https://doi.org/10.3390/cancers13071683

Thebault, Eric, Sophie Piperno-Neumann, Diep Tran, Hélène Pacquement, Perrine Marec-Berard, Cyril Lervat, Marie-Pierre Castex, Morgane Cleirec, Emmanuelle Bompas, Jean-Pierre Vannier, and et al. 2021. "Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?" Cancers 13, no. 7: 1683. https://doi.org/10.3390/cancers13071683

Thebault, E., Piperno-Neumann, S., Tran, D., Pacquement, H., Marec-Berard, P., Lervat, C., Castex, M.-P., Cleirec, M., Bompas, E., Vannier, J.-P., Plantaz, D., Saumet, L., Verite, C., Collard, O., Pluchart, C., Briandet, C., Monard, L., Brugieres, L., Le Deley, M.-C., & Gaspar, N. (2021). Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials? Cancers, 13(7), 1683. https://doi.org/10.3390/cancers13071683